uz
Feedback
Chennai Trading Academy

Chennai Trading Academy

Kanalga Telegram’da o‘tish

Not SEBI registered Trades given in this group are for educational purposes only. Consult your financial advisor before taking any trade and trade at your own risk.

Ko'proq ko'rsatish

📈 Telegram kanali Chennai Trading Academy analitikasi

Chennai Trading Academy (@ctanarayanan) Ingliz til segmentidagi kanali faol ishtirokchi. Hozirda hamjamiyat 20 820 obunachidan iborat bo'lib, Iqtisodiyot & Moliya toifasida 5 983-o'rinni va Hindiston mintaqasida 20 241-o'rinni egallagan.

📊 Auditoriya ko‘rsatkichlari va dinamika

невідомо sanasidan buyon loyiha tez o‘sib, 20 820 obunachiga ega bo‘ldi.

21 Iyul, 2026 dagi oxirgi ma’lumotlarga ko‘ra kanal barqaror faollikka ega. Oxirgi 30 kunda obunachilar soni 58 ga, so‘nggi 24 soatda esa 36 ga o‘zgardi va umumiy qamrov yuqori darajada qolmoqda.

  • Tasdiqlash holati: Tasdiqlanmagan
  • Jalb etish (ER): Auditoriya o‘rtacha 11.38% darajada jalb etiladi. Nashrdan keyingi dastlabki 24 soatda kontent odatda umumiy obunachilar sonining 10.23% ini tashkil etuvchi reaksiyalarni to‘playdi.
  • Post qamrovi: Har bir post o‘rtacha 2 369 marta ko‘riladi; birinchi sutkada odatda 2 130 ta ko‘rish yig‘iladi.
  • Reaksiyalar va o‘zaro ta’sir: Auditoriya faol: har bir postga o‘rtacha 3 ta reaksiya keladi.
  • Tematik yo‘nalishlar: Kontent hdfc, yoy, crore, insurance, ipo kabi asosiy mavzularga jamlangan.

📝 Tavsif va kontent siyosati

Muallif resursni shaxsiy fikrni ifoda etish maydoni sifatida ta’riflaydi:
Not SEBI registered Trades given in this group are for educational purposes only. Consult your financial advisor before taking any trade and trade at your own risk.

Yuqori yangilanish chastotasi (oxirgi ma’lumot 22 Iyul, 2026 da olingan) sababli kanal doimo dolzarb va katta qamrovli bo‘lib qoladi. Analitika auditoriya kontent bilan faol hamkorlik qilishini, uni Iqtisodiyot & Moliya toifasidagi muhim ta’sir nuqtasiga aylantirishini ko‘rsatadi.

20 820
Obunachilar
+3624 soatlar
+1087 kunlar
+5830 kunlar
Postlar arxiv
Intraday levels in NIFTY AND BANKNIFTY , please msg to WhatsApp number by clicking the below Link 》》 https://wa.me/919003091909?text=I%20Want%20To%20Open%20an%20Account Intraday levels in CRUDEOIL AND NATURAL GAS, please msg to WhatsApp number by clicking the below Link 》》 https://wa.me/919003091909?text=I%20Want%20To%20Open%20an%20Accout

*𝗥𝗘𝗦𝗨𝗟𝗧𝗦 𝗧𝗼𝗺𝗼𝗿𝗿𝗼𝘄 𝗧𝗵𝘂𝗿𝘀𝗱𝗮𝘆 𝗡𝗶𝗳𝘁𝘆 Stocks 𝗜𝗡𝗙𝗢𝗦𝗬𝗦 𝗜𝗡𝗧𝗘𝗥𝗚𝗟𝗢𝗕𝗘 𝗖𝗜𝗣𝗟𝗔 F&O Stocks 𝗠𝗢𝗙𝗦𝗟 𝗩𝗜𝗦𝗛𝗔𝗟 𝗠𝗘𝗚𝗔 𝗠𝗔𝗥𝗧 𝗦𝗢𝗡𝗔 𝗕𝗟𝗪 𝗠𝗣𝗛𝗔𝗦𝗜𝗦 𝗜𝗘𝗫 𝗖𝗮𝘀𝗵 Stocks 𝗠𝗘𝗘𝗦𝗛𝗢 𝗖𝗢𝗥𝗢𝗠𝗔𝗡𝗗𝗘𝗟 𝗜𝗡𝗧𝗘𝗥𝗡𝗔𝗧𝗜𝗢𝗡𝗔𝗟 𝗚𝗢 𝗗𝗜𝗚𝗜𝗧 𝗖𝗛𝗘𝗡𝗡𝗔𝗜 𝗣𝗘𝗧𝗥𝗢 𝗔𝗟𝗟𝗜𝗘𝗗 𝗕𝗟𝗘𝗡𝗗𝗘𝗥𝗦 𝗨𝗝𝗝𝗜𝗩𝗔𝗡 𝗦𝗙𝗕 𝗣𝗩𝗥𝗜𝗡𝗢𝗫 𝗖𝗬𝗜𝗘𝗡𝗧 𝗧𝗛𝗬𝗥𝗢𝗖𝗔𝗥𝗘 𝗧𝗘𝗖𝗛𝗡𝗢𝗟𝗢𝗚𝗜𝗘𝗦 𝗠𝗔𝗛𝗜𝗡𝗗𝗥𝗔 𝗟𝗜𝗙𝗘𝗦𝗣𝗔𝗖𝗘 𝗥𝗢𝗨𝗧𝗘 𝗠𝗢𝗕𝗜𝗟𝗘 𝗦𝗣𝗔𝗡𝗗𝗔𝗡𝗔 𝗦𝗣𝗛𝗢𝗢𝗥𝗧𝗬 𝗦𝗨𝗥𝗬𝗢𝗗𝗔𝗬 𝗦𝗙𝗕 𝗖𝗔𝗣𝗜𝗧𝗔𝗟 𝗦𝗙𝗕*

NESTLE Stellar Set! Massive Beat on Revenue, EBITDA & PAT - Revenue at 6378 Cr vs Poll at 6065 Cr - EBITDA at 1538 Cr vs Poll at 1375 Cr - Margins at 24% vs Poll at 22.7% - PAT at 975 Cr vs Poll at 857 Cr YoY Growth - Revenue +25% - EBITDA +40% - PAT +48% Key Internals - Strong quarter led by volume growth - Domestic Sales +25%, Exports +36% - Accelerated operational cost savings, yet grew ad spends by >40% - All product groups delivered strong double-digit growth

photo content

photo content

BSE In Focus – Set To Be Part Of Nifty 50? NSE circular on NIFTY 50 came yesterday NSE uploaded the methodology for index rej
+1
BSE In Focus – Set To Be Part Of Nifty 50? NSE circular on NIFTY 50 came yesterday NSE uploaded the methodology for index rejig No change in methodology As per this, BSE is set to be part of the Nifty 50 index, replacing Wipro As per an earlier Axis Cap note, BSE inclusion will lead to passive inflow of $657 million (around Rs 6300 cr)

10 Years no return Symphony -5% SPARC: -5% Emami: -5% Network18: -3% Huhtakami: -2% ACC: -2% Blue Dart: -2% PNB: -2% Castrol: -1% Whirlpool: 0% PVR Inox: -0.5% Amara Raja 0% LIC Housing: 1% Shopperstop 1% Indus Tower 1% Kiri Ind: 1.5% Nilkamal: 1.50% ITC: +2% IDBI: +2% Bata: +2% VST Ind: 2% JK Lakshmi Cem: 3% Just Dial: 3% Jyoti Lab: 3% Dabur: 3% Hero Moto: 4%

Trump’s Generic Pharma Tariff Plan: Winners & Losers? 🇺🇸 Proposed policy: ✅0% tariff on imported generic drugs for the next 2 years (from Aug 1). 🙁100% tariff in Year 3. 🙁200% tariff thereafter. Likely impact (if implemented): 🟢 Potential Beneficiaries 🔥Aurobindo Pharma – Strong US manufacturing footprint. 🔥Senores Pharma – Local US manufacturing could be an advantage. ☠️Sentimentally Negative 🙁Dr. Reddy’s 🙁Lupin 🙁Cipla 🙁Zydus (US manufacturing exists but may not be sufficient if tariffs become steep.) ⚪ Largely Neutral 😄Alkem 😄Torrent (Lower dependence on US generics profits.) If this policy becomes reality, manufacturing location could become as important as product quality.

Strong growth by NESTLE in Q1 Double Digit volume growth delivered in the quarter Stock up 3% post results
Strong growth by NESTLE in Q1 Double Digit volume growth delivered in the quarter Stock up 3% post results

SOLID + BUMPER Results from TVS Motors EBITDA growth is more than 40%
SOLID + BUMPER Results from TVS Motors EBITDA growth is more than 40%

NEGATIVE FOR INDIAN PHARMA STOCKS This is an unexpected development given the past news flow on this account Expect knee jerk negative reaction across the board for Indian generic cos with large US exposure - Auro, Zydus, Lupin, DRL most exposed in large caps; Strides, Rubicon etc in smaller names; cos like sun with limited generic exposure, Cipla with a relatively stronger US mfg base are relatively better placed at the margin Beyond the headlines, too many unanswered questions - does it apply only to formulations or also on APIs, are countries with trade deal exempted as is with branded drugs: clarity will emerge only when the formal regulations are issued The tariff threat for branded drugs was managed by agreements between big pharma and Trump admin, country level trade deals and a flurry of capex announcements BROKER NOTE

ADANIENT hit day high...Watch Adani stocks

WIPRO hit day high….Watch IT stocks

DATAPATTNS Up 4% Today….Good Volume

NIFTY SPOT NEAR 24000 NOW THIS IS LAST 8 SESSION LOW THIS WILL KEEP CRUCIAL SUPPORT TODAY

MotilalOswalLtd note: Paytm - Revenue growth steady; EBITDA margin improves | Neutral | TP INR1,475

ALL SECTORAL INDICES except Auto down Today Nifty Auto Up +0.6% Today PSU Bank & Pharma Leads the Fall

KALYANKJIL Trading Near 52 Week High....Good Volume Stock Up 2% Today